by Flamingo Strategies | Aug 9, 2024 | Blog
EptivA present PainCLOUD® at the International Association for the Study of Pain (IASP) World Congress 2024 Amsterdam Late Breaking Poster Presentation – #TH408 TITLE: PainCLOUD® – A Novel in-silico Network Biology Methodology to Develop Personalized...
by Flamingo Strategies | Aug 2, 2024 | Blog
Why is Pain Research and Development So Expensive? In this article, we will explore why pain research is so expensive, and how our B2B platform, Pain Cloud®, can help to reduce these costs, paving the way for a brighter future for pain patients and the market as a...
by Flamingo Strategies | Jul 3, 2024 | Blog
How Pain Cloud® Tackles the Challenges of Target Validation Did you know that one in four people worldwide are suffering from chronic pain? Read on to find out how our B2B platform, Pain Cloud®, can help you improve your POS while putting patients first. The chronic...
by Flamingo Strategies | Jun 11, 2024 | Press Release
Pain Cloud® Launch: A Collaboration between EptivA and Infopoly Ltd., creating an advanced solution to Pain Research. It has been over a decade since the last new chronic pain medicine was approved by regulators, even though 1.5 billion people currently suffer chronic...
by Flamingo Strategies | Jun 6, 2024 | News
Pain Cloud at IASP World Congress on Pain We’re pleased to announce that EptivA Therapeutics Ltd’s ‘Late Breaking Poster Submission’ has been accepted for presentation at the IASP World Congress on Pain, taking place from 5 – 9 August 2024 in...
Recent Comments